BioCentury
ARTICLE | Clinical News

Affimed preclinical data

May 19, 2008 7:00 AM UTC

In a tumorigenic fibrosarcoma cell line, IgG1-iS18 reduced the number of invasive cells by 38% compared with untreated cells (p=0.03). The antibody against laminin receptor precursor/laminin receptor...